(Q35660829)

9 August 2017

1 reference

title

Target organ involvement in hypertension: a realistic promise of prevention and reversal (English)

1 reference

9 August 2017

1

Edward D Frohlich

1 reference

9 August 2017

publication date

1 January 2004

1 reference

Medical Clinics of North America

9 August 2017

published in

1 reference

9 August 2017

volume

88

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

209-221

1 reference

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Blood pressure, stroke, and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

A meta-analysis of outcome trials in elderly hypertensives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

International Society of Hypertension (ISH)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

The Natural History of Congestive Heart Failure: The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

State of the Art lecture. Risk mechanisms in hypertensive heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Diastolic dysfunction in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Structural remodeling in hypertensive heart disease and the role of hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Mechanism of angina pectoris in patients with systemic hypertension and normal epicardial coronary arteries by arteriogram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Distinct endothelial impairment in coronary microvessels from hypertensive Dahl rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

The heart in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Is reversal of left ventricular hypertrophy in hypertension beneficial?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Coronary hemodynamics in aging spontaneously hypertensive and normotensive Wistar-Kyoto rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Regional blood flow in normotensive and spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Pharmacologic agents on cardiovascular mass, coronary dynamics and collagen in aged spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Dissociation of changes in cardiovascular mass and performance with angiotensin-converting enzyme inhibitors in Wistar-Kyoto and spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Coronary hemodynamic and ventricular responses to angiotensin type 1 receptor inhibition in SHR: interaction with angiotensin type 2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Biochemical components and myocardial performance after reversal of left ventricular hypertrophy in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Disparate structural effects on left and right ventricles by angiotensin-converting enzyme inhibitors and calcium antagonists in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Prolonged L-arginine on cardiovascular mass and myocardial hemodynamics and collagen in aged spontaneously hypertensive rats and normal rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

L-arginine reverses severe nephrosclerosis in aged spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Isolated systolic hypertension in elderly WKY is reversed with L-arginine and ACE inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Management of diabetic and hypertensive cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Glomerular dynamics and morphology of aged spontaneously hypertensive rats. Effects of angiotensin-converting enzyme inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Nitric oxide synthase inhibition in spontaneously hypertensive rats. Systemic, renal, and glomerular hemodynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Hydrochlorothiazide exacerbates nitric oxide-blockade nephrosclerosis with glomerular hypertension in spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Renoprotective effects of felodipine and/or enalapril in spontaneously hypertensive rats with and without L-NAME

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2803%2900117-2

10.1016/S0025-7125(03)00117-2

7 January 2021

Identifiers

DOI

1 reference

9 August 2017

1 reference